Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator-Reference-Cited by-同舟云学术

Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator

Published:2016 Issue:3 Volume:66 Page:44-50
ISSN:0022-9717
Container-title:The Keio Journal of Medicine
language:en
Short-container-title:Keio J. Med.

Author:

Yoshida Tadashi¹,Hayashi Matsuhiko¹

Affiliation:

1. Apheresis and Dialysis Center, Keio University School of Medicine, Tokyo, Japan

Publisher

Keio Journal of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/kjm/66/3/66_2016-0009-OA/_pdf

Reference24 articles.

1. 1. Hsu CY, McCulloch CE, Curhan GC: Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13: 504–510. PMID:11805181

2. 2. Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995; 25: 548–554. PMID:7702049, DOI:10.1016/0272-6386(95)90122-1

3. 3. Kuwahara M, Iimori S, Kuyama T, Akita W, Mori Y, Asai T, Tsukamoto Y, Adachi S, Rai T, Uchida S, Sasaki S: Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis. Clin Exp Nephrol 2011; 15: 121–125. PMID:21069412, DOI:10.1007/s10157-010-0360-6

4. 4. Walker AM, Schneider G, Yeaw J, Nordstrom B, Robbins S, Pettitt D: Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine. J Am Soc Nephrol 2006; 17: 2293–2298. PMID:16837634, DOI:10.1681/ASN.2005020183

5. 5. Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R: Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006; 21: 370–377. PMID:16249203, DOI:10.1093/ndt/gfi209

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients;International Urology and Nephrology;2021-07-15

2. Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation;Clinical and Experimental Nephrology;2020-10-06

3. Effect of statin on life prognosis in Japanese patients undergoing hemodialysis;PLOS ONE;2019-10-22

4. Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis;BMC Nephrology;2019-06-07

5. Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels;Annals of Transplantation;2019-05-10